Navigation

polysaccharide iron (Niferex, Hytinic, Ferrex, FeTinic, Polysaccharide Iron Complex)

 

Classes: Iron Products

Dosing and uses of Niferex, Hytinic (polysaccharide iron)

 

Adult dosage forms and strengths

capsule

  • 150mg

 

Prevention/Treatment of Iron Deficiency

150-300 mg PO q8hr

 

Administration

For maximum absorption take on empty stomach, but may take with or after meals to minimize GI irritation

Vitamin C may enhance absorption

 

Pediatric dosage forms and strengths

capsule

  • 150 mg

 

Treatment of Iron-deficiency Anemia

Preemie: 2-4 mg Fe/kg/day PO qDay divided q12hr; not to exceed 15 mg/day

Children: 3-6 mg Fe/kg/day PO qDay divided q12hr

 

Iron-deficiency Anemia, Prophylaxis

Preemie: 2 mg Fe/kg/day PO PO qDay divided q8hr; not to exceed 15 mg/day

Children: 1-2 mg Fe/kg/day PO qDay divided q8hr; not to exceed 15 mg/day

>10 Years Old

  • Males: 2 mg/day Fe PO
  • Females: 5 mg/day Fe PO

 

Administration

For maximum absorption take on empty stomach, but may take with or after meals to minimize GI irritation

Vitamin C may enhance absorption

 

Niferex, Hytinic (polysaccharide iron) adverse (side) effects

Frequency not defined

Nausea

Constipation

Stomach carmping

epigastric pain

Diarrhea

Vomiting

Discolored urine

Dark stools

Heartburn

Staining of teeth

Abdominal pain

 

Warnings

Contraindications

Hypersensitivity

Hemochromatosis, hemosiderosis, hemolytic anemia, PUD, ulcerative colitis

 

Cautions

Type of anemia & causes of it should be determined prior to treatment

Iron can be harmful or fatal to children in large doses

 

Pregnancy and lactation

Pregnancy category: A

Lactation: consult physician

 

Pregnancy categories

A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

NA: Information not available.

 

Pharmacology of Niferex, Hytinic (polysaccharide iron)

Mechanism of action

Essential nutrient, component of heme & nonheme iron proteins; works as cofactor of several essential enzymes, including cytochromes, which are involved in electron transport